FibroBiologics, Inc. (FBLG)
1.36
-0.07
(-4.90%)
USD |
NASDAQ |
Sep 21, 16:00
1.32
-0.04
(-2.94%)
After-Hours: 20:00
FibroBiologics Market Cap : 8.270M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 8.270M |
| September 18, 2026 | 8.695M |
| September 17, 2026 | 9.030M |
| September 16, 2026 | 8.695M |
| September 15, 2026 | 8.756M |
| September 14, 2026 | 9.425M |
| September 11, 2026 | 9.790M |
| September 10, 2026 | 10.52M |
| September 09, 2026 | 10.70M |
| September 08, 2026 | 10.40M |
| September 04, 2026 | 11.01M |
| September 03, 2026 | 10.70M |
| September 02, 2026 | 11.86M |
| September 01, 2026 | 12.83M |
| August 31, 2026 | 10.46M |
| August 28, 2026 | 8.756M |
| August 27, 2026 | 9.060M |
| August 26, 2026 | 8.574M |
| August 25, 2026 | 8.513M |
| August 24, 2026 | 8.209M |
| August 21, 2026 | 8.756M |
| August 20, 2026 | 7.844M |
| August 19, 2026 | 7.236M |
| August 18, 2026 | 6.932M |
| August 17, 2026 | 6.202M |
| Date | Value |
|---|---|
| August 14, 2026 | 6.445M |
| August 13, 2026 | 6.993M |
| August 12, 2026 | 6.750M |
| August 11, 2026 | 6.263M |
| August 10, 2026 | 5.959M |
| August 07, 2026 | 5.936M |
| August 06, 2026 | 6.202M |
| August 05, 2026 | 5.278M |
| August 04, 2026 | 4.998M |
| August 03, 2026 | 4.807M |
| July 31, 2026 | 4.256M |
| July 30, 2026 | 4.373M |
| July 29, 2026 | 3.980M |
| July 28, 2026 | 3.955M |
| July 27, 2026 | 2.203M |
| July 24, 2026 | 2.501M |
| July 23, 2026 | 2.584M |
| July 22, 2026 | 2.600M |
| July 21, 2026 | 2.716M |
| July 20, 2026 | 2.744M |
| July 17, 2026 | 2.933M |
| July 16, 2026 | 2.950M |
| July 15, 2026 | 2.961M |
| July 14, 2026 | 2.992M |
| July 13, 2026 | 3.016M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.67B |
| Anika Therapeutics, Inc. | 277.03M |
| Savara, Inc. | 1.119B |
| Vericel Corp. | 2.024B |
Market Cap Related Metrics
| PEG Ratio | -0.0084 |
| Price to Book Value | 1.784 |
| Price | 1.36 |
| Earnings Yield | -414.7% |
| PEGY Ratio | -0.0084 |